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Abstract
Background: Acetaminophen overdose (AO) is the most common cause of acute liver failure.
We examined temporal trends and sociodemographic risk factors for AO in a large Canadian
health region.
Methods: 1,543 patients hospitalized for AO in the Calgary Health Region (population ~1.1
million) between 1995 and 2004 were identified using administrative data.
Results:  The age/sex-adjusted hospitalization rate decreased by 41% from 19.6 per 100,000
population in 1995 to 12.1 per 100,000 in 2004 (P < 0.0005). This decline was greater in females
than males (46% vs. 29%). Whereas rates fell 46% in individuals under 50 years, a 50% increase was
seen in those ≥ 50 years. Hospitalization rates for intentional overdoses fell from 16.6 per 100,000
in 1995 to 8.6 per 100,000 in 2004 (2004 vs. 1995: rate ratio [RR] 0.49; P < 0.0005). Accidental
overdoses decreased between 1995 and 2002, but increased to above baseline levels by 2004 (2004
vs. 1995: RR 1.24;P < 0.0005). Risk factors for AO included female sex (RR 2.19; P < 0.0005),
Aboriginal status (RR 4.04; P < 0.0005), and receipt of social assistance (RR 5.15; P < 0.0005).
Conclusion: Hospitalization rates for AO, particularly intentional ingestions, have fallen in our
Canadian health region between 1995 and 2004. Young patients, especially females, Aboriginals, and
recipients of social assistance, are at highest risk.
Background
Acetaminophen is the most commonly implicated drug in
cases of acute liver failure (ALF) predominantly due to its
widespread availability [1-5]. Excluding combination
preparations, approximately 1.5 billion tablets are sold
annually in Canada[6]. Recent data from the US ALF
Study Group identified acetaminophen as the etiology in
approximately 50% of cases[2,3]. Acetaminophen over-
dose typically has a good prognosis, even if hepatic failure
has developed. Less than 5% of patients who take toxic
quantities of acetaminophen (approximately 150 mg/kg
body weight) develop acute liver toxicity [7]. and survival
without transplantation for those who develop encepha-
lopathy (~65%) exceeds that for most other forms of ALF
[2-4]. Nevertheless, nearly one-third of those developing
encephalopathy will die and 8% require transplantation
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[2-4]. The cost of treating patients with acetaminophen
overdose was estimated at over $87 million annually in
the US in 1995;[8] this is likely a conservative estimate in
light of current health care costs.
Due to these important public health implications, a
wealth of literature has focused on the epidemiology of
acetaminophen overdose [9-19]. Most reports originate in
the United Kingdom (UK) where legislation in 1998 lim-
ited the size of packets of acetaminophen to 16 tablets of
500 mg[9,10]. Although results are variable, most studies
suggest a benefit of this legislation. In a systematic review
examining the impact of these restrictions, Morgan et al.
reported a reduction in hospital admissions and liver
transplants for acetaminophen overdose, but conflicting
findings regarding the severity of poisonings, deaths, and
over the counter sales following this legislation[11].
Recently, Prior et al. examined the epidemiology of aceta-
minophen overdose in Canada[6]. Between 1995 and
2002, the annual hospitalization rate for acetaminophen
overdose was 27 per 100,000 population. This rate did
not change significantly after the lifting of restrictions lim-
iting sales of acetaminophen (tablets > 325 mg or quanti-
ties > 24 tablets) to pharmacies only in 1999–2000[6].
Unfortunately, this study did not describe the characteris-
tics of patients with acetaminophen overdose, including
sociodemographic factors. Studies have suggested that
younger age and female gender increase the risk of aceta-
minophen overdose,[12,13] but Canadian data is lacking.
Therefore, we conducted a population-based study to
examine risk factors for acetaminophen overdose in a
large Canadian health region. We were particularly inter-
ested in the impact of Aboriginal race and low socioeco-
nomic status on rates of acetaminophen overdose since a
wealth of literature has demonstrated greater health dis-
parities, including an increased risk of suicide, in Aborigi-
nal [14,15] and lower income Canadians[16,17]. We also
examined temporal trends in hospitalization rates for
acetaminophen overdose, including both intentional and
accidental ingestions. An understanding of the predispos-
ing factors for acetaminophen overdose might permit tar-
geting of preventive initiatives at high risk subgroups if a
substantial need is uncovered by the epidemiologic anal-
ysis.
Methods
Study population
The study population consisted of hospitalized patients
with acetaminophen overdose residing in the Calgary
Health Region (CHR) between fiscal years 1995 to 2004.
The CHR provides virtually all medical and surgical care
to approximately 1.1 million residents of Calgary and sur-
rounding communities in the southern part of the prov-
ince of Alberta. Hospitalized acetaminophen overdose
cases were identified using CHR hospital discharge
abstract administrative data. This database contains 16
diagnosis and 10 procedure coding fields. Cases of aceta-
minophen overdose were identified via a search of the 16
diagnosis coding fields for diagnostic code 965.4 accord-
ing to the International Classification of Disease, Ninth Revi-
sion, Clinical Modification (ICD-9-CM) [18] in the 1995–
2001 discharge data, and T39.1 according to ICD-10 [19]
in the 2002–2004 discharge data. Trained health records
nosologists at each hospital code all diagnoses prior to
submission of the data to Alberta Health and Wellness.
Coding is based on the entire hospital record. Non-resi-
dents of the CHR were excluded. The first admission was
assigned as the index admission for patients with repeated
hospitalizations for acetaminophen overdose.
Definitions of variables
The identified acetaminophen overdose cases were linked
with the Alberta Health Care Insurance Plan (AHCIP)
Registry [20]. using a unique personal health number.
Since the ACHIP is a government-administered universal
plan providing health care for over 99% of Albertans, this
registry includes nearly all residents of Alberta[20].
Demographics and information regarding Aboriginal and
socioeconomic status (SES) were extracted from this regis-
try. Aboriginal status was ascertained using a field that
identifies individuals with "Treaty status" based on trea-
ties between their First Nations bands and the federal gov-
ernment, which entitle patients to comprehensive health
care without insurance premiums[20,21]. As a proxy for
low SES, the receipt of social assistance or an insurance
premium subsidy from Alberta Health and Wellness were
examined. In 2004, 2% of Albertans received social assist-
ance and 13% received a subsidy. All individuals 65 years
of age and older (herein referred to as seniors) are eligible
for this subsidy regardless of income. Due to the methods
of coding in the AHCIP Registry, receipt of a subsidy or
social assistance could not be determined in status Abo-
riginals.
Comorbid depression was defined using ICD-9-CM and
ICD-10 coding algorithms developed by Quan et al. [22].
Alcohol-related diagnoses were defined using a previ-
ously-validated ICD-9-CM diagnosis coding algorithm for
discharge data from fiscal years 1995–2001[23,24]. We
translated  ICD-9-CM  codes to corresponding ICD-10
codes for 2002–2004 discharge data via a search of both
coding manuals. All 16 diagnosis fields were used to
define these comorbidities.
The circumstance in which the overdose occurred was
classified as accidental (ICD-9-CM, E850.4, E935.4; ICD-
10, X40, Y45.5), intentional (ICD-9-CM, E950.0;ICD-10,
X60), or other (including homicidal [ICD-9-CM,BMC Public Health 2007, 7:143 http://www.biomedcentral.com/1471-2458/7/143
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E962;ICD-10, X85] and undetermined intent) using
'external causes of injury' codes (E-codes). These codes are
frequently used to define injuries according to mechanism
(eg. poison, firearm, motor vehicle) and intent (eg. acci-
dental, suicide, assault)[25]. Any overdose involving self-
inflicted poisoning by another drug, medicinal or biolog-
ical substance in addition to acetaminophen (ICD-9-CM,
E950.1-E952.9;ICD-10, X61-X69) was considered inten-
tional.
Statistical methods
Descriptive statistical methods were used to describe
demographic and clinical characteristics of patients with
acetaminophen overdose at their first hospitalization. We
also compared patients with single versus multiple hospi-
talizations to identify characteristics that might be partic-
ularly strong risk factors for acetaminophen overdose.
Between group comparisons were made using Fisher's
exact, χ2, and Mann-Whitney tests, as appropriate. Hospi-
talization rates were calculated by considering the entire
end-of-fiscal year population of the CHR (as obtained
from the AHCIP Registry) as at risk. Direct age/sex-
adjusted rates were calculated using the 2001 Canadian
population as the standard. Temporal trends in hospitali-
zation rates and selected risk factors (age, gender) for
acetaminophen overdose were evaluated using Poisson
log-linear regression[26]. The impact of Aboriginal status,
and receipt of social assistance or an insurance premium
subsidy on rates of acetaminophen overdose were deter-
mined by comparing the prevalence of these indicators
among acetaminophen overdose cases versus the remain-
der of the population using Fisher's exact test.
The study protocol was approved by the Conjoint Health
Research Ethics Board at the University of Calgary.
Results
Study population
Between 1995 and 2004, 1,543 patients had 1,680 admis-
sions for acetaminophen overdose. The majority (68%)
was female and the median age at first hospitalization was
26 years (interquartile range [IQR], 2–85) (Table 1).
Females were significantly younger than males at presen-
tation (median age [IQR]: 24 [12–84] vs. 29 [2–76] years;
z = -5.69; P < 0.0005). Thirty-two percent (n = 486) were
less than 20 years of age; only 4.5% (n = 70) were 60 years
or greater. Of all patients, 7% were status Aboriginals, and
11% and 15% received social assistance or an insurance
premium subsidy, respectively. Compared with patients
hospitalized only once, those with multiple hospitaliza-
tions were more likely to be on social assistance (17% vs.
11%; z = -2.11; P = 0.04) and Aboriginal (14% vs. 7%; z =
-2.83; P = 0.005) (Table 1).
Depression or at least one alcohol-related diagnosis were
recorded in 55% (n = 842) and 33% (n = 515) of the
patients, respectively; 17% (n = 270) had both conditions.
The most common alcohol-related diagnoses were alco-
hol abuse (12%), alcohol dependence disorders (11%),
and alcohol-related psychiatric disorders (15%). Alcohol-
related diagnoses were more common in males (47% vs.
27%; z = -7.52; P < 0.0005) and Aboriginals (65% vs.
31%; z = -7.29; P < 0.0005), but did not differ according
to receipt of social assistance or an insurance premium
subsidy. Alcohol-related diagnoses, but not depression,
were more common in patients with multiple versus sin-
gle hospitalizations for acetaminophen overdose (Table
1).
The majority of the overdoses (85%) were intentional.
Only 13% were accidental and 2% were homicidal (n = 3)
Table 1: Characteristics of patients hospitalized for acetaminophen overdose *
Characteristic All patients (n = 1,543) Single hospitalization (n = 1,434) Multiple hospitalizations 
(n = 109)
P-value **
Demographics
Age, years 26 (2–85) 26 (2–85) 27 (14–55) 0.91
Female gender 68% (1,054) 68% (975) 72% (79) 0.20
Aboriginal status 7% (109) 7% (94) 14% (15) 0.005
Social assistance 11% (174) 11% (155) 17% (19) 0.04
Subsidy 15% (226) 15% (215) 10% (11) 0.16
Depression 55% (842) 54% (774) 62% (68) 0.09
Alcohol-related diagnosis 33% (515) 33% (467) 44% (48) 0.01
Circumstance of overdose
Intentional 85% (1,427) ‡ 85% (1,215) 88% (96) 0.73
Accidental 13% (220) ‡ 13% (193) 11% (12)
Other 2% (33) ‡ 2% (26) 1% (1)
* Data at first hospitalization. All data are medians (interquartile range) or proportions (% [n]).
** For comparison of patients with single versus multiple hospitalizations.
‡ Percentages calculated based on total number of overdoses (n = 1,680).BMC Public Health 2007, 7:143 http://www.biomedcentral.com/1471-2458/7/143
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or of undetermined intent (n = 30) (Table 1). The propor-
tion with intentional overdoses decreased with advancing
age (chi2 [7 df] = 166.3; P = 0.0001; Figure 1). Only 45%
(22/49) of overdoses in seniors were intentional versus
86% (1,405/1,631) in younger patients (z = 7.95; P <
0.0005). All overdoses in patients under 10 years (n = 11)
were accidental.
Hospitalization rates
Between 1995 and 2004, the age/sex-adjusted annual hos-
pitalization rate for acetaminophen overdose was 15.5 per
100,000 population. Females were approximately twice as
likely to be hospitalized. Age-adjusted rates in females
and males were 21.3 and 9.7 per 100,000, respectively
(rate ratio [RR]: 2.19; z = 472.16; P < 0.0005). Hospitali-
zation rates decreased by 41% between 1995 and 2004
(Figure 2). The adjusted hospitalization rate in 1995 was
19.6 per 100,000 versus 12.1 per 100,000 in 2004. This
decline was more marked in females than males (46% vs.
29%). Hospitalization rates declined steadily for inten-
tional overdoses from 16.6 per 100,000 in 1995 to 8.6 per
100,000 in 2004 (2004 vs. 1995: RR 0.49; z = -178.52; P
< 0.0005) (Figure 3). On the contrary, accidental over-
doses decreased during the middle years of the interval
and increased back above baseline levels by 2004 (2004
vs. 1995: RR 1.24; z = 26.49; P < 0.005) (Figure 3). Over-
doses of other causes fluctuated at low levels (Figure 3).
The highest hospitalization rates were observed in the 10–
19 and 20–29 year age groups (35.5 and 30.3 per 100,000
population, respectively) (Figure 4). These groups were
nearly three-times as likely to have an overdose compared
with patients 30 years and older (RR 2.76; z = 648.30; P <
0.0005). Excluding patients under 10 years, hospitaliza-
tion rates were significantly higher in females (Figure 4).
The greatest disparity was seen in the 10–19 year age
group in whom the crude hospitalization rate was 55.4
per 100,000 in females versus only 13.0 per 100,000 in
males (RR 4.24; z = 398.04; P < 0.0005).
Trends in hospitalization rates for acetaminophen over-
dose varied by age group (Figure 5). Between 1995 and
2004, rates declined in both males and females under 50
years (2004 vs. 1995: males, RR 0.62 [z = -69.71; P <
0.0005]; females, RR 0.51 [z = -148.78; P < 0.0005]; over-
all, RR 0.54; z = -164.13;P < 0.0005). In patients 50 years
and over, rates tended to fluctuate (Figure 5). Compared
with 1995, rates in 2004 were higher in both males and
females (2004 vs. 1995: males, RR 1.86 [z = 33.58; P <
0.0005]; females, RR 1.29 [z = 17.43; P < 0.0005]; overall,
RR 1.50 [z = 35.60; P < 0.0005).
Aboriginal status and receipt of social assistance were
important risk factors for acetaminophen overdose. The
RRs of Aboriginal status and social assistance were 4.04 (P
Annual age/sex-adjusted hospitalization rates for acetami- nophen overdose by intention and year (1995–2004) Figure 3
Annual age/sex-adjusted hospitalization rates for acetami-
nophen overdose by intention and year (1995–2004).
Cases of acetaminophen overdose in the Calgary Health  Region by age and intention (1995–2004) Figure 1
Cases of acetaminophen overdose in the Calgary Health 
Region by age and intention (1995–2004).
Annual age-adjusted hospitalization rates for acetaminophen  overdose by sex (1995–2004) Figure 2
Annual age-adjusted hospitalization rates for acetaminophen 
overdose by sex (1995–2004).BMC Public Health 2007, 7:143 http://www.biomedcentral.com/1471-2458/7/143
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< 0.0005) and 5.16 (P < 0.0005), respectively. Receipt of
an insurance premium subsidy was not a significant risk
factor (RR 0.97; P = 0.74).
Discussion
In this population-based study, we examined trends in
hospitalization rates for acetaminophen overdose in a
large Canadian health region. Between 1995 and 2004,
the adjusted annual hospitalization rate for acetami-
nophen overdose was 15.5 per 100,000 population. This
rate is approximately one-fifth of that reported in the UK
despite legislation limiting sales of acetaminophen in that
country[12,27,28]. Although the explanations for this dis-
crepancy are beyond the scope of this study, differences in
acetaminophen availability seem unlikely considering the
relatively liberal sale of acetaminophen in Canada. More-
over, suicide rates are similar in the UK and Can-
ada[29,30]. Presumably, this discrepancy reflects different
methods of suicide in the two countries (eg. more fre-
quent use of firearms, hanging, and suffocation in Canada
versus poisoning in the UK)[29,30]. We also report a 41%
decline in the annual rate of hospitalization between
1995 and 2004. This decline was more pronounced in
females, younger patients (under 50 years), and for inten-
tional overdoses. Our study is at odds with a recent Cana-
dian epidemiologic investigation of acetaminophen
overdose[6]. In this analysis of Canada-wide hospital dis-
charge data, Prior et al. reported only a slight decrease
(~10%) in hospitalization rates for acetaminophen over-
dose between 1995 and 2001 (vs. 30% in our study). The
purpose of this study was to examine the impact of the lift-
ing of place-of-sale restrictions in 1999 on rates of aceta-
minophen overdose. Provincial data for Alberta was
aggregated with that of other provinces (Nova Scotia and
Prince Edward Island) that did not have restrictions prior
to this time point. Therefore, data specific to our health
region or Alberta cannot be extracted from this report. Of
pertinence is that overdose rates in our health region
appear to differ from other regions, even within Alberta.
For example, Colman et al. reported much lower rates of
emergency department visits for self-inflicted injuries in
Calgary compared with Edmonton (the other major city
in the province) during the same time period[31]. This
finding likely reflects differences in the underlying popu-
lations. Since low SES appears to be associated with aceta-
minophen overdose (see below), the relative prosperity of
the CHR due to its high concentration of petroleum com-
panies may account for the lower rates that we observed.
The majority of the data from other countries supports
our observation. Although US data is limited, Nourjah et
al. reported a 10% decline in acetaminophen-related 'poi-
son control calls' to centers involved in the Toxic Exposure
Surveillance System between 1997 and 2001[13]. Simi-
larly, Turvill et al. reported declines of 21% and 64% in all
acetaminophen overdoses and severe overdoses, respec-
tively, presenting to the Royal Free Hospital in London
between 1995 and 2002[28]. In Scotland, Bateman et al.
reported an increase in hospitalizations from 1990 to
1997 followed by an approximate 20% decrease between
1997 and 1999 (2000–2004 data was not reported)[12].
Hughes et al. also reported a fall in hospital admissions for
acetaminophen overdose in Birmingham between 1995
and 1999[32]. These reductions have been attributed to
legislation limiting the sale of acetaminophen in the UK
The fall in hospitalization rates in our region is somewhat
surprising since efforts to reduce acetaminophen over-
dose, including package size restrictions, have not been
undertaken. Colman et al. actually reported an increase in
visits to emergency departments in Alberta for self-
inflicted injuries during this time period (but trends in
acetaminophen overdose were not reported)[31]. In addi-
tion, Canadian suicide rates have remained stable during
Trends in crude hospitalization rates for acetaminophen  overdose by age group (< vs. ≥ 50 years) and sex (1995– 2004) Figure 5
Trends in crude hospitalization rates for acetaminophen 
overdose by age group (< vs. ≥ 50 years) and sex (1995–
2004).
Crude hospitalization rates for acetaminophen overdose by  age and sex (1995–2004) Figure 4
Crude hospitalization rates for acetaminophen overdose by 
age and sex (1995–2004).BMC Public Health 2007, 7:143 http://www.biomedcentral.com/1471-2458/7/143
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the past two decades[29]. Presumably this conflicting data
relates to shifting trends in methods of suicide[29]. Huch-
croft et al. observed a decline in self-poisoning deaths in
Canadian females, but an increase in suicides due to hang-
ing, strangulation and suffocation in males[33]. An alter-
native explanation is that thresholds for hospitalizing
patients with acetaminophen overdose have become
more stringent. Increasing demand for hospital beds and
greater experience managing these patients are possible
explanations. Because our data does not represent all inci-
dent cases, we cannot confirm these speculations.
Hospitalization rates for accidental acetaminophen over-
dose appeared to rise during the latter years of our study
following an initial decline between 1995 and 2002. Such
'therapeutic misadventures' [34,35] occurred in 13% of
our study population. This finding is in keeping with data
from the US ALF Study Group reporting that a striking
50% of ALF cases due to acetaminophen were acciden-
tal[2]. Based on this data, it has been estimated that
approximately 500 ALF cases and 150 deaths attributable
to unintentional overdoses occur annually in the US[36].
Since accidental ingestions have been linked with a
greater risk of hepatotoxicity, [3,37-39] our observation of
a recent increase is of public health importance. Currently
over 100 products containing sometimes large amounts
of acetaminophen are available over-the-counter, and
many patients (and physicians) are unaware of their
acetaminophen content[36]. The observed increase in
hospitalization rate coincides with the availability of
extended release acetaminophen preparations in Canada
(since 1999); misinformation about the proper dosing of
these formulations may have played a role. Our data
emphasizes the necessity of educational initiatives regard-
ing the safe use of acetaminophen and clear labeling of
medications with their acetaminophen content so that
this trend does not continue.
A major strength of our data is the examination of popu-
lation-based, sociodemographic risk factors for acetami-
nophen overdose. As reported in other studies, females,
especially those in their teenage years and twenties, are at
greatest risk[6,12,28,32,40-44]. Hospitalization rates are
four to five-fold higher among individuals who require
social assistance and status Aboriginals. High rates of sui-
cidal behaviour have been reported in the Aboriginal
communities of Canada and other countries,[45,46].
emphasizing the necessity of suicide prevention strategies
in this population. Presumably sociodemographic factors
contribute to this risk, but this could not be examined spe-
cifically due to coding methods among Aboriginals in our
databases. The high rate of alcohol-related diagnoses in
our study cohort (33%), particularly among status Aborig-
inals (64%), likely contributed to the risk of acetami-
nophen overdose in these subgroups[47].
Another strength of our study is the use of population-
based data from a large geographic region. Many prior
studies have originated in referral centres, including liver
transplant units, and are prone to selection bias[2-5,38].
For example, data from the US ALF Study Group suggests
that the proportion of ALF cases due to acetaminophen
overdose is on the rise[2]. However, since denominator
data is not available in this type of study due to the recruit-
ment methods, population-based studies such as our own
are necessary to truly appreciate trends in rates of acetami-
nophen overdose. Moreover, part of the explanation for
the apparently increasing rates in this study (versus the
decrease that we observed) is that the proportion of ALF
cases due to viral hepatitis has fallen presumably as a
result of widespread vaccination. This shift in etiologies
has likely led to an overemphasis of the importance of
acetaminophen overdose in current data.
Our study has several limitations. First, the validity of cod-
ing suicidal intent in patients with acetaminophen over-
dose has not been validated. However, studies of other
conditions have suggested that E-codes provide a reliable
indication of suicidal intent[48,49]. For example, LeMier
et al. reported 95% agreement between E-codes obtained
from administrative data and medical record review for
defining suicidal intent in a variety of injuries including
poisonings, falls, and firearm incidents. For poisonings
specifically, agreement was 87%[48]. In another study of
adult subscribers to a health maintenance organization in
California, medical record reviews confirmed that 86% of
hospitalizations assigned "intentional" E-codes were sui-
cide attempts[49]. An additional limitation of our study is
the reliance on discharge data to identify only hospital-
ized cases, which clearly underestimates the true inci-
dence of acetaminophen overdose. Patients who didn't
seek medical attention or weren't hospitalized would not
have been captured by our search strategy. However, we
have identified the most clinically relevant cases at the
highest risk of adverse outcomes and consumption of
health care resources.
Conclusion
Rates of acetaminophen overdose, particularly intentional
ingestions, have fallen in our Canadian health region
between 1995 and 2004. Young patients, especially
females, Aboriginals, and recipients of social assistance,
are at highest risk.
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